| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.00044 | 1 |